WOODCLIFF LAKE, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that the Company’s unaudited financial statements for the three and six months ended June 30, 2025, are available at https://investor.eagleus.com/events-presentations. About Eagle Pharmaceuticals, Inc.Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and BYFAVO® and BARHEMSYS® through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s oncology and CNS/metabolic critical care pipeline includes...

Management to discuss third quarter 2025 results and host investor Q&A at virtual eventeXp World Holdings to Announce Third Quarter 2025 Results on November 6, 2025Management to discuss third quarter 2025 results and host investor Q&A at virtual eventBELLINGHAM, Wash., Oct. 15, 2025 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI), the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced it expects to report its third quarter 2025 financial results on Thursday, November 6, 2025. The Company will hold a virtual fireside chat and investor Q&A on Thursday, November 6, 2025 at 2 p.m. PT / 5 p.m. ET hosted by:Glenn Sanford, Founder, Chairman and CEO, eXp World Holdings Leo Pareja, CEO, eXp Realty Wendy Forsythe, CMO, eXp Realty Jesse Hill, Chief Financial Officer,...

DALLAS, Oct. 15, 2025 (GLOBE NEWSWIRE) — Triumph Financial, Inc. (NYSE: TFIN) has released its third quarter 2025 financial results. The 3Q 2025 financial results and shareholder letter are available on the Company’s website at ir.triumph.io through the News & Events, Events & Presentations links. Aaron P. Graft, Vice Chairman & CEO, and Brad Voss, CFO, will review the financial results in a conference call with investors and analysts beginning at 9:30 a.m. central time on Thursday, October 16, 2025. The live video conference option may be accessed directly through this link, https://triumph-financial-q3-2025-earnings.open-exchange.net/ or via the Company’s IR website at ir.triumph.io through the News & Events, Events & Presentations links. An archive of this conference call will subsequently be available...

Gross Revenue of US$98.64 Million and Cash Cost of US$814/Oz VANCOUVER, British Columbia, Oct. 15, 2025 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” today announced its annual financial results for the year ended June 30, 2025 (“Fiscal 2025” or “FY 2025”). All amounts are in United States dollars unless otherwise indicated (refer to www.sedar.com for full financial results). Fiscal 2025 gold production generated gross revenue of $98.64 million, compared to $51.42 million. Net earnings of $37.54 million, or $0.11 per share, up significantly from $6.44 million, or $0.02 per share, in the prior year. The Company’s financial position has improved markedly, with cash flow rising to $48.65 million from $14.39 million last year, cash on hand increasing to $45.94 million from $10.86...

OSE Immunotherapeutics Reports First Half 2025 Financial Results NANTES, France, October 15, 2025 – 7:00pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today reported its consolidated financial results for the first half of 2025. The half-year financial statements for 2025 were subject to a limited review by the Company’s statutory auditors and were approved by the Board of Directors on October 15, 2025. 2025 Half-Year Financial Results (IFRS)In million euros H1 2024 H1 2025Revenues 69.0 1.3Other income 13.5 0.0Operating income 82.6 1.4Research and development expenses (13.9) (14.8)General and administrative expenses (4.3) (4.5)Share-based payments expenses (1.1) (2.2)Other operating items – 4.4Operating profit (loss) 63.3 (15.8)Financial income (loss) (2.6) 0.8Net income...

JONESTOWN, Pa., Oct. 15, 2025 (GLOBE NEWSWIRE) — JBT Bancorp, Inc. (OTCQX: JBTC) reported quarterly earnings of $3,261,000 or $1.34 per share for the third quarter of 2025. Nine-month reported earnings are $7,116,000 or $2.92 per share, up from $5,780,000 or $2.37 per share in the prior year, representing a 23% increase in earnings. The company also increased its quarterly dividend to 29 cents per share, up 2 cents over the prior quarter. President & CEO Troy A. Peters stated: “JBT has a long and consistent dividend history and we are happy to have the financial performance that allows us to again increase our dividend to shareholders.” Strong margin performance continues to be a key driver of profitability. Importantly, net interest income has improved and is up 10.4% over last year. More information can be found at OTC Markets...

PRESS RELEASE Nanterre, October 15, 2025 VINCI Airports – Traffic as of September 30, 2025Traffic up 4.2% in Q3 2025 compared to Q3 2024; +3.6% in September 2025 compared to September 2024 High level of traffic in August on most European platforms Very good traffic dynamics in Japan, Mexico, Brazil and Cabo VerdeIn the paragraphs below, and unless otherwise stated, the variations refer to traffic levels for the 3rd quarter of 2025 compared to the 3rd quarter of 2024. VINCI Airports recorded strong traffic growth in the third quarter, welcoming 94 million passengers, up 4.2% year-on-year, or 3.8 million additional travelers. Summer 2025 was characterized by good traffic performance at most airports. High load factors and an increasing airline seat supply fueled this expansion. Some hubs performed particularly well: resort destinations...

Reported Improved Gross Margin from Contribution from Higher-Margin Product MixOperating Expenses Continued to Decline Compared to the First Quarter of the Prior Fiscal Year, Reflecting the Company’s Ongoing Focus on Cost Reduction and Operational EfficiencyEarnings per Share $0.00, Compared to a Net Loss of $0.08 per Share in the First Quarter of the Prior Fiscal Year.IRVINE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), (“Biomerica” or the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the first quarter ended August 31, 2025. Key Highlights:inFoods® IBS receives Proprietary Laboratory Analysis (“PLA”) Code The American Medical Association CPT Editorial Panel has issued a PLA code...

RENO, Nev., Oct. 15, 2025 (GLOBE NEWSWIRE) — Plumas Bancorp (Nasdaq:PLBC), the parent company of Plumas Bank, today announced earnings during the third quarter of 2025 of $5.1 million or $0.74 per share, a decrease of $2.7 million from $7.8 million or $1.33 per share during the third quarter of 2024.   Diluted earnings per share decreased to $0.73 per share during the three months ended September 30, 2025, down from $1.31 per share during the quarter ended September 30, 2024. Net interest income increased $6.3 million in the quarter and the provision for income taxes declined by $1.1million. These items were offset by an increase of $5.8 million in the provision for credit losses and an increase of $4.3 million in non-interest expense.  The annualized return on average assets was 0.90% for the three months ended September 30, 2025,...

Laying the foundation for a major revenue surge anticipated in FY2026 SHENZHEN, China, Oct. 15, 2025 (GLOBE NEWSWIRE) — Jayud Global Logistics Limited (NASDAQ: JYD) (“Jayud” or the “Company”), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced its unaudited financial results for the six months ended June 30, 2025. Financial HighlightsTotal revenues increased 3.7% year-over-year to $39.2 million, as a result of the significant increase of $2.1 million in international trading business. Net income was $0.3 million, a notable recovery from the $2.7 million net loss recorded in the six months ended June 30, 2024. Basic and diluted earnings per share was $0.003, compared to a loss per share of $0.12 in the prior-year period. Total assets...